BDBM698591 (R)-1-(6-(4-(5,6-dichloro-1H-indazol-4-yl)-3-(2,2-dimethyl-4-((4-(oxetan-3-yl)piperazin-1-yl)methyl)piperidin-1-yl)-5-methyl-1H-pyrazol-1-yl)-2-azaspiro[3.3]heptan-2-yl)prop-2-en-1-one::US20240317721, Example 243b

SMILES C=CC(=O)N1CC2(CC(n3nc(N4CC[C@@H](CN5CCN(C6COC6)CC5)CC4(C)C)c(-c4c(Cl)c(Cl)cc5[nH]ncc45)c3C)C2)C1

InChI Key InChIKey=AGXDGCACUVIDKM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 698591   

TargetGTPase KRas [G12C](Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 698591BDBM698591((R)-1-(6-(4-(5,6-dichloro-1H-indazol-4-yl)-3-(2,2-...)
Affinity DataIC50: 6nMAssay Description:Assays were run using 384-well plates (781207/Greiner) in which one column was designated as the high signal (no inhibition) control, and contained D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent